• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: Claire Temple (Marvel Cinematic Universe)     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : dbo:FictionalCharacter, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)

Type: Thingdul:Agentagentwikidata:Q24229398Character (arts)fictional character New Facet based on Instances of this Class

Claire Temple is a fictional character portrayed by Rosario Dawson in several of the Marvel Cinematic Universe (MCU) television series, created as a composite character based on both the Marvel Comics characters Claire Temple and Night Nurse (aka Linda Carter). A nurse who gives medical aid to vigilantes, she was created for the first season of Daredevil (2015). Dawson then signed a deal to return for the second season of the series (2016), as well as potentially appear in any other Marvel Netflix series. She has since reprised the role in Jessica Jones (2015), Luke Cage (2016–2018), Iron Fist (2017–2018), and The Defenders (2017). The character has also appeared in a Jessica Jones tie-in comic (2015), and has received a positive critical reception.